India Pharma News - Latest Updates & Headlines
India ranked 11th in global pharma exports in 2023: Centre
New Delhi, March 11: With the government taking several measures to ensure the quality, safety and efficacy of medicines, the Indian pharmaceutical exports ranked 11th globally in value terms in the year 2023, Anupriya Patel, Union Minister of State for Chemicals and Fertilisers, said in the Rajya Sabha on Tuesday.
Regulatory violations in India's pharma sector fell 11pc in 2024
New Delhi, Feb 27: India's pharmaceutical industry has witnessed a sharp drop of 11 per cent in regulatory violation instances in 2024, according to a report.
India becoming an attractive option for global pharmaceutical supply chain: Macquarie Report
New Delhi, February 20: India's Contract Research, Development, and Manufacturing Organization (CRDMO) industry is on a strong growth trajectory, with its market size expected to double from the current approx. USD 7 billion to approx. USD 14 billion by 2028, according to a report by Macquarie Equity Research.
India's Pharma market to expand 2.4 times over next 5 years, share in global market to hit 5 pc: Report
New Delhi, February 11: India's pharmaceutical industry is poised for significant growth, with its share in the global market expected to rise to 5 per cent by 2030, according to a report by Bain & Company.
India's pharma exports has potential to reach $350 billion by 2047: Report
New Delhi, Feb 9: India's pharmaceutical exports are projected to double from approximately $27 billion in 2023 to reach $65 billion by 2030, and can further grow to an estimated $350 billion by 2047, according to a new report.
China+1 opens larger share for India in global pharma manufacturing beyond generics: BCG report
New Delhi, January 27: India is poised to capture a bigger share of the global pharmaceutical manufacturing market beyond generics, according to a report by Boston Consulting Group (BCG).
India, US can strengthen ties in healthcare security and affordability: Indian Pharmaceutical Alliance Secretary General
By Shalini Bhardwaj, New Delhi, January 21: As the US remains the top market for the Indian pharmaceutical industry, experts in India are now expecting opportunities for collaboration in healthcare security and affordability following the new US administration under President Donald Trump, stated Sudarshan Jain, Secretary General of the Indian Pharmaceutical Alliance.
Budget 2025 must introduce measures to drive innovation, manufacturing in health, pharma: Experts
New Delhi, Jan 14: The Union Budget 2025 must introduce transformative measures that drive innovation, manufacturing, and export competitiveness in healthcare and pharma sectors, said experts on Tuesday.